Mankind Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: MANKIND BSE: 543904

About Mankind Pharma Limited

Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.

Source: Wikipedia

Key facts

BSE symbol543904
NSE symbolMANKIND
ISININE634S01028
CINL74899DL1991PLC044843
Listing date9 May 2023
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorAMIT GUPTA & ASSOCIATES (AMIT GUPTA)
Registered office208, Okhla Industrial Estate, Phase-III, New Delhi-110020
Registrar & transfer agentKFin Technologies Limited Selenium, Tower B, Plot No - 31 & 32, Financial District, Nanakramguda, Serilingampally, Hyderabad Rangareddi, Telangana - 500032

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23
Total income (before exceptional items)10,746†9,988†9,531†—
Net profit2,0381,9451,8231,248

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Rajeev JunejaExecutive DirectorJune 30, 2026
Ramesh JunejaExecutive DirectorJune 30, 2026
Satish Kumar SharmaExecutive DirectorJune 30, 2026
Sheetal AroraExecutive DirectorJune 30, 2026
Bharat AnandIndependent DirectorJune 30, 2026
Tilokchand Punamchand OstwalIndependent DirectorJune 30, 2026
Vijaya SampathIndependent DirectorJune 30, 2026
Vivek Santokh KalraIndependent DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.